Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age.
Journal: The Journal of infectious diseases
Published: December 23, 2025
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial.
Journal: Nature communications
Published: December 06, 2024
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
Journal: The Journal of infectious diseases
Published: February 07, 2024
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain.
Journal: The Journal of investigative dermatology
Published: May 09, 2019
Showing 1-4 of 4
Last Updated: 09/26/2026